SCHOFIELD, Wis., Dec. 6, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience Inc. (OTCBB:PMBS) announced today that it has received an initial series of purchase orders for its new over-the-counter migraine medication, LipiGesic®M with the second largest chain drug retailer in the United States, CVS. This follows a recent announcement that LipiGesic®M is now available nationwide at Walgreens, the largest chain of drug stores in the United States.
